ACTU
ACTUATE THERAP (ACTU)
NASDAQ
$1.85+$0.02 (+1.37%)
Price as of Jun 03, 2026 6:35 PM EDT
  • $48.3M
    Market Cap
  • -80.02%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-10.3M
-44.89%
-18.7M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
Total Operating Expenses
22.5M
-10.59%
25.2M
N/A
Operating Profit
-22.5M
-10.59%
-25.2M
N/A
Interest Income
287,710
+29.43%
222,293
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
287,710
+29.43%
222,293
N/A
Total Nonoperating Income and Expense
267,460
+112.59%
-2.1M
N/A
Income before Taxes
-22.5M
-10.59%
-25.2M
N/A
Income Taxes
800
0.00%
800
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
-27.3M
N/A
Net Income from Continuing Operations Applicable to Common
N/A
N/A
-27.3M
N/A
Basic EPS and Net Income
-1.06
-67.48%
-3.26
N/A
Diluted EPS and Net Income
-1.06
-67.48%
-3.26
N/A
Basic Weighted Average Shares
21.0M
+151.07%
8.4M
N/A
Diluted Weighted Average Shares
21.0M
+151.07%
8.4M
N/A
Balance Sheet
Cash and Cash Equivalents
13.2M
+52.28%
8.6M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
13.2M
+52.28%
8.6M
N/A
Total Current Assets
13.6M
+48.17%
9.2M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
Total Long-Term Assets
392,491
+255.04%
110,548
N/A
Total Assets
14.0M
+50.62%
9.3M
N/A
Income Taxes Payable
3.2M
-46.48%
5.9M
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
Total Current Liabilities
5.7M
-35.17%
8.8M
N/A
Total Long-Term Debt
0
N/A
0
N/A
Total Long-Term Liabilities
404,991
-1.64%
411,759
N/A
Total Liabilities
6.1M
-33.67%
9.2M
N/A
Retained Earnings
-154.6M
+16.79%
-132.4M
N/A
Total Stockholders Equity
N/A
N/A
104,186
N/A
Total Shares Outstanding
23.2M
+19.01%
19.5M
N/A
Cash Flow
Cash from Operating Activities
-19.2M
-12.07%
-21.8M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
23.7M
-13.81%
27.5M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
Return on Equity
N/A
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
2.39
N/A
N/A
N/A
Cash Ratio
2.31
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow